These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15612449)

  • 1. Effects of type 2 diabetes on the regulation of hepatic glucose metabolism.
    Basu A; Shah P; Nielsen M; Basu R; Rizza RA
    J Investig Med; 2004 Sep; 52(6):366-74. PubMed ID: 15612449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues.
    Firth RG; Bell PM; Marsh HM; Hansen I; Rizza RA
    J Clin Invest; 1986 May; 77(5):1525-32. PubMed ID: 3517067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a change in the pattern of insulin delivery on carbohydrate tolerance in diabetic and nondiabetic humans in the presence of differing degrees of insulin resistance.
    Basu A; Alzaid A; Dinneen S; Caumo A; Cobelli C; Rizza RA
    J Clin Invest; 1996 May; 97(10):2351-61. PubMed ID: 8636416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution to postprandial hyperglycemia and effect on initial splanchnic glucose clearance of hepatic glucose cycling in glucose-intolerant or NIDDM patients.
    Butler PC; Rizza RA
    Diabetes; 1991 Jan; 40(1):73-81. PubMed ID: 2015976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity.
    Basu A; Basu R; Shah P; Vella A; Johnson CM; Nair KS; Jensen MD; Schwenk WF; Rizza RA
    Diabetes; 2000 Feb; 49(2):272-83. PubMed ID: 10868944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of insulin action and glucose effectiveness in diabetic and nondiabetic humans.
    Alzaid AA; Dinneen SF; Turk DJ; Caumo A; Cobelli C; Rizza RA
    J Clin Invest; 1994 Dec; 94(6):2341-8. PubMed ID: 7989590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type I diabetes mellitus does not alter initial splanchnic glucose extraction or hepatic UDP-glucose flux during enteral glucose administration.
    Vella A; Shah P; Basu R; Basu A; Camilleri M; Schwenk WF; Rizza RA
    Diabetologia; 2001 Jun; 44(6):729-37. PubMed ID: 11440366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy.
    Rizza RA
    Diabetes; 2010 Nov; 59(11):2697-707. PubMed ID: 20705776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of dysregulated glucagon secretion in type 2 diabetes.
    D'Alessio D
    Diabetes Obes Metab; 2011 Oct; 13 Suppl 1():126-32. PubMed ID: 21824266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal renal, hepatic, and muscle glucose metabolism following glucose ingestion in type 2 diabetes.
    Meyer C; Woerle HJ; Dostou JM; Welle SL; Gerich JE
    Am J Physiol Endocrinol Metab; 2004 Dec; 287(6):E1049-56. PubMed ID: 15304374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of GLP-1 induced glucagon suppression in type 2 diabetes mellitus.
    Hare KJ
    Dan Med Bull; 2010 Sep; 57(9):B4181. PubMed ID: 20816021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
    Kotronen A; Juurinen L; Tiikkainen M; Vehkavaara S; Yki-Järvinen H
    Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of hepatic glucose production and glucose uptake in the pathogenesis of fasting hyperglycemia in type 2 diabetes: normalization of glucose kinetics by short-term fasting.
    Féry F
    J Clin Endocrinol Metab; 1994 Mar; 78(3):536-42. PubMed ID: 8126123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon, a key factor in the pathophysiology of type 2 diabetes.
    Girard J
    Biochimie; 2017 Dec; 143():33-36. PubMed ID: 29024725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The key role of islet dysfunction in type II diabetes mellitus.
    Porte D; Kahn SE
    Clin Invest Med; 1995 Aug; 18(4):247-54. PubMed ID: 8549009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Physiopathological fundamentals of type 2 diabetes].
    Girard J
    Rev Prat; 1999 Jan; 49(1):22-9. PubMed ID: 9926712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes.
    Woerle HJ; Szoke E; Meyer C; Dostou JM; Wittlin SD; Gosmanov NR; Welle SL; Gerich JE
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E67-E77. PubMed ID: 16105859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients.
    Immonen H; Hannukainen JC; Iozzo P; Soinio M; Salminen P; Saunavaara V; Borra R; Parkkola R; Mari A; Lehtimäki T; Pham T; Laine J; Kärjä V; Pihlajamäki J; Nelimarkka L; Nuutila P
    J Hepatol; 2014 Feb; 60(2):377-83. PubMed ID: 24060855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of pancreas transplantation on postprandial glucose metabolism.
    Katz H; Homan M; Velosa J; Robertson P; Rizza R
    N Engl J Med; 1991 Oct; 325(18):1278-83. PubMed ID: 1922222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.